Images List Premium Download Classic

Obstructive Sleep Apnea

Obstructive Sleep Apnea-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Stimulation of a hypoglossal nerve for controlling the position of a patient's tongue
Imthera Medical, Inc.
August 10, 2017 - N°20170224988

A method for controlling a position of a patient's tongue includes attaching at least one electrode to the patient's hypoglossal nerve, applying an electric signal through the electrode to the hypoglossal nerve to stimulate at least one muscle of the tongue at least until the number of obstructive sleep apnea occurrences are reduced from an initial level to a treatment ...
System for stimulating a hypoglossal nerve for controlling the position of a patient's tongue
Imthera Medical, Inc.
August 03, 2017 - N°20170216590

A system for controlling a position of a patient's tongue includes attaching at least one electrode to the patient's hypoglossal nerve and applying an electric signal through the electrode to at least one targeted motor efferent located within the hypoglossal nerve to stimulate at least one muscle of the tongue. The system may also include the use of more than ...
Hybrid oral device
Achaemenid, Llc
July 27, 2017 - N°20170209300

An oral device for treating obstructive sleep apnea is generally described. In an embodiment, the oral device includes an anchoring member, a lip sealing member and an air transmission member configured to receive and transmit air to a user. The air transmission member may divide and distribute the air to multiple locations within the user's oral cavity. The anchoring member ...
Obstructive Sleep Apnea Patent Pack
Download + patent application PDFs
Obstructive Sleep Apnea Patent Applications
Download + Obstructive Sleep Apnea-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Obstructive Sleep Apnea-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Use of gabaa receptor antagonists for the treatment of excessive sleepiness and disorders associated with ...
Emory University
July 13, 2017 - N°20170196885

Gabaa receptor mediated hypersomnia can be treated by administering a gabaa receptor antagonist (e. G., flumazenil; clarithromycin; picrotoxin; bicuculline; cicutoxin; and oenanthotoxin). In some embodiments, the gabaa receptor antagonist is flumazenil or clarithromycin. The gabaa receptor mediated hypersomnia includes shift work sleep disorder, obstructive sleep apnea/hypopnea syndrome, narcolepsy, excessive sleepiness, hypersomnia (e. G., idiopathic hypersomnia; recurrent hypersomnia; endozepine related ...
Tongue grasping and restraining apparatus and methods
Emory University
July 06, 2017 - N°20170189223

A tongue grasping and restraining device holds the tongue securely during sleep in order to minimize the risk of the tongue slipping back and blocking the throat, a condition known as obstructive sleep apnea. Plural tongue gripping projections are coupled to upper and lower supports. The projections engage and hold the tongue. The upper and lower supports are biased toward ...
System and method for training tongue as a treatment for obstructive sleep apnea
Cornell University
June 29, 2017 - N°20170182358

The present disclosure describes systems and methods for the treatment of obstructive sleep apnea. The system includes a mouthpiece. The mouthpiece includes a force plate that a user can press against with their tongue. Pressing the force plate enables the user to strengthen their tongue. The system also includes a control module that can measure the force applied to the ...
Obstructive Sleep Apnea Patent Pack
Download + patent application PDFs
Obstructive Sleep Apnea Patent Applications
Download + Obstructive Sleep Apnea-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Obstructive Sleep Apnea-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Apparatus, systems, and methods for treating obstructive sleep apnea
Fresca Medical Inc.
June 08, 2017 - N°20170157356

Apparatus, systems, and methods are provided for treating obstructive sleep apnea. A cpap system with an integrated oximeter sensor is disclosed wherein the sensor communicates with an oximeter processor that controls the blower. A nasal air flow sensor may also be incorporated that provides more data to the processor. A unique lightweight, flexible and stretchable hose for cpap systems is ...
Custom made oral appliance for airway management of those with obstructive sleep apnea (osa)
Fresca Medical Inc.
June 01, 2017 - N°20170151086

An oral appliance for managing a person's airway and for a more efficient breathing is disclosed. The oral appliance provides greater comfort by maintaining an open air passage through the mouth and by preventing the tongue from blocking the windpipe during sleep. The appliance has a mouthpiece that includes partial tooth trays capable of adjustable multidirectional movements relative to each ...
Oxytocin improves treatment of obstructive sleep apnea
Fresca Medical Inc.
May 25, 2017 - N°20170143790

The present disclosure provides methods for treating obstructive sleep apnea (osa) and osa induced cardiorespiratory diseases. The disclosure provides, inter alia, methods for treating or alleviating: osa or osa induced hypertension, cardiac arrhythmias, myocardial ischemia, sudden cardiac death or stroke, by administering oxytocin. The disclosure further provides methods for improving sleep satisfaction in osa patients by administering oxytocin.
Method of stimulating a hypoglossal nerve for controlling the position of a patient's tongue
Imthera Medical, Inc.
May 04, 2017 - N°20170120050

A method for controlling a position of a patient's tongue includes attaching at least one electrode to the patient's hypoglossal nerve and applying an electric signal through the electrode to at least one targeted motor efferent located within the hypoglossal nerve to stimulate at least one muscle of the tongue. Methods may also include the use of more than one ...
Systems, methods and devices for diagnosing sleep apnea
Imthera Medical, Inc.
May 04, 2017 - N°20170119306

Methods for diagnosing sleep apnea are provided herein. In at least one example, a method may be provided including receiving airway image data from a remote end imaging sensor coupled to a nasal tube disposed within an upper airway above a constriction point, and analyzing the airway image data and displaying in a sleep study report the airway image data ...
System and method for treating obstructive sleep apnea
The Cleveland Clinic Foundation
April 20, 2017 - N°20170106190

One aspect of the present disclosure relates to a system for treating obstructive sleep apnea in a subject. The system can include a power source and a neuromuscular stimulator in electrical communications with the power source. The neuromuscular stimulator can include a controller and at least one electrode. The controller can be configured to receive certain power and stimulation parameters ...
Use of retinoic acid and analogs thereof to treat central neural apneas
Wisconsin Alumni Research Foundation
April 13, 2017 - N°20170100358

Described is a method of inhibiting central apnea, central hypopnea or obstructive sleep apnea in a mammal. The method includes the step of administering to a mammal a central apnea inhibitory-effective, central hypopnea inhibitory-effective or obstructive sleep apnea inhibitory-effective amount of a composition comprising at least one retinoid or retinoid or retinoic acid receptor agonist.
Obstructive Sleep Apnea Patent Pack
Download + patent application PDFs
Obstructive Sleep Apnea Patent Applications
Download + Obstructive Sleep Apnea-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Obstructive Sleep Apnea-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Apparatus for measuring properties of gases supplied to a patient
Fisher & Paykel Healthcare Limited
April 06, 2017 - N°20170095632

The gases temperature supplied to a patient when the patient is undergoing treatment such as oxygen therapy or positive pressure treatment for conditions such as obstructive sleep apnea (osa) or chronic obstructive pulmonary disease (copd) is often measured for safety and to enable controlling of the humidity delivered to the patient. The invention disclosed is related to measurement of properties, ...
Partially erodable systems for treatment of obstructive sleep apnea
Fisher & Paykel Healthcare Limited
March 09, 2017 - N°20170065452

The invention relates to devices and methods for reforming tissue surrounding the airway of a subject suffering from obstructive sleep apnea so as to open the airway and alleviate the occurrence of apneic events. Devices comprise a combination of resiliently deformable material and bioerodible material. The deformable portion of the device has a preferred shape that corresponds to the desired ...
Nasopharyngeal device for obstructive sleep apnea syndrome
Fisher & Paykel Healthcare Limited
February 23, 2017 - N°20170049981

The system and method for reducing or eliminating obstructive sleep apnea in patients with the use of a nasopharyngeal device. The nasopharyngeal device has an obturator including reversibly expandable projections located at a distal end and a guide portion on a proximal end. The reversibly expandable projections are adapted to maintain patency of the nasopharyngeal airway by advancing anteriorly the ...
Oral device for treating sleep disordered breathing disorders
Catholic University Industry-academic Cooperation Foundation
February 09, 2017 - N°20170035601

The present invention relates to an oral device for treatment of sleep disordered breathing that includes an upper body in which at least a part of upper teeth is housed; a lower body in which at least a part of the lower teeth is housed; at least one or more elastic members that connect the upper body and the lower ...
A mucoadhesive tongue strip used as a method to prevent snoring and sleep apnea during ...
Catholic University Industry-academic Cooperation Foundation
February 02, 2017 - N°20170027738

A comfortable mucoadhesive tongue strip that is applied to the tip of the tongue to keep the tongue in its restive position so as to reduce or eliminate the harmful effects of obstructive sleep apnea and disruptive snoring during sleep.
Oral devices, kits and methods for reducing sleep apnea, snoring, and/or nasal drainage
W. R. Wagner Family Limited Partnership
December 22, 2016 - N°20160367394

Apparatus for reducing obstructive sleep apnea, snoring and/or nasal drainage. One apparatus includes an upper member fitting the interior and exterior surfaces of a user's upper dentition, and a lower member fitting similarly adjacent a user's lower dentition. The lower member includes molar extensions projecting away from the lower member. The upper member includes upper molar extensions projecting away ...
System and method of detecting sleep disorders
W. R. Wagner Family Limited Partnership
December 22, 2016 - N°20160367203

An apparatus for detecting sleep disorders, such as obstructive sleep apnea, includes a housing insertable into an ear canal of a subject. A sensor disposed within the housing measures a position of the subject's head relative to an axis of gravity. A transducer is responsive to the sensor and is capable of creating a stimulus detectable by the subject under ...
Glp-1 receptor agonist compounds for obstructive sleep apnea
Eli Lilly & Company
December 15, 2016 - N°20160361390

The disclosure provides, among other things, the use of glp-1 receptor agonist compounds to treat obstructive sleep apnea. The glp-1 receptor agonist compounds may be exendins, exendin analogs, glp-1 (7-37), glp-1 (7-37) analogs (e. G., glp-1 (7-36)-nh2) and the like. The glp-1 receptor agonist compound may be exenatide.
Loading